Warrington-headquartered Assura has given notice under its revolving credit facility agreement to voluntarily cancel £100m of the existing £225m finance package.

The facility runs to November 2024.

Following this notice by the company, the RCF stands at £125 million and is currently undrawn.

Assura, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long[1]term investor in and developer of primary care property.

The company works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.

At 31 March 2021, Assura’s property portfolio was valued at £2.45bn.